1. Lung Health Study I, II, III
  2. The Lung Cancer Substudy (LCS). 1994-1999
  3. A Multicenter Evaluation of the Effects of Zyban versus Placebo in a population of smokers with COPD. Glaxo-Welcome 1998-2000
  4. A Double-Blind Randomized, Placebo and Active Controlled Multicenter, Parallel Group, Dose Ranging Study of L753099 in Patients with COPD. Merk & Co. 2000
  5. A Randomized, double-blind, parallel group trial assessing the efficacy and safety in subjects at least 12 years of age with chronic asthma currently treated with inhaled corticosteroids. Glaxo-Welcome, Inc. 2000
  6. Efficacy and safety of MF-DPI in the Treatment of Patients with Chronic Obstructive Pulmonary Disease. Schering Plough. 2001-2002
  7. A randomized, 24 week, double-blind, placebo controlled, parallel group study to evaluate the efficacy and tolerability of Ariflo (15 mg BID) in patients with Chronic Obstructive Pulmonary Disease. Glaxo-Smithkline. 2001-2002
  8. A phase IIIB, multicenter, randomized, double-blind, placebo-controlled, parallel group trial assessing the rate of decline of lung function with Tiotropium 18 mcg inhalation capsule once daily in patients with chronic obstructive pulmonary disease


You can help the Division of Pulmonary Medicine continue to progress with even a small contribution. Give today!